Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) Blocker

NCT01444833 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

35

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Candesartan

Sponsor

Slovak Academy of Sciences